Here's an example of what's due today

Trial-access debate

Mon, Nov 23, 2026 · Week 14 · Genetics of Disease (Medical Interventions)

Today's goal: Argue a position on who should get access to experimental cancer drugs through clinical trials and right-to-try laws.

Learn first

What a finished product looks like

This is a model of the work you should turn in today. Use it to check your own: match the structure and the level of detail, do not copy it. Your data and wording should be your own.

Worked CER on a parallel case
Completes: Models the exact CER deliverable (Claim, Evidence, Reasoning) on a parallel bioethics access case so students can copy the structure and depth, not the answer: a single-sentence claim naming who should decide, evidence drawn from how the medical system actually handles the case, and reasoning that ties the evidence back to the claim.

Parallel case (not today's prompt): A 12-year-old is the only close tissue match to donate a kidney to a sibling in kidney failure. The child says yes, but a minor cannot legally give full informed consent. Should the parents, the transplant surgeon, a hospital ethics committee, or the child have the final say on whether the donation happens?\n\nClaim: A hospital ethics committee, not the parents or the surgeon alone, should have the final say on whether a minor donates a kidney to a sibling, with the child given a real chance to refuse.\n\nEvidence: Living kidney donation is a surgery a healthy person does not medically need, and it carries real risks such as bleeding, infection, and the loss of one of two working kidneys for life. A 12-year-old cannot legally give informed consent, so someone else must decide for them. Parents have a clear interest in saving the sick child, which can pull them toward saying yes even when it is not in the donor child's best interest. For this reason, most transplant centers require a separate donor advocate and review by an independent ethics committee before a minor is allowed to donate, and courts have stepped in when a family and a hospital disagreed.\n\nReasoning: The person facing the risk of surgery is the donor child, but that child cannot legally weigh those risks alone, so the decision has to be shared. Handing the final say to the parents alone creates a conflict of interest, because they are also trying to save their other child, and handing it to the surgeon alone puts one person in charge of a life-altering choice for a healthy patient. An independent ethics committee is built to check exactly this kind of pressure: it can confirm the medical facts, protect the donor child's right to say no, and make sure the decision serves the donor and not only the sibling in need. That is why the committee, with the child's voice included, should hold the final say.

Also due today: Record the class vote and your final stance, and submit the exit ticket to the course shell before leaving class.

Check yourself

WebXam problem for today's skill

One exam-style question that uses exactly what you practiced today. Try it before you reveal the answer, then read why each choice is right or wrong.

WebXam-style domain: Biotechnology Research and ExperimentsSelf-check skill: Explaining the role of clinical trials and right-to-try in drug access
A new cancer drug has not finished clinical trials. A terminally ill patient wants to try it now. Which statement correctly describes why clinical trials normally gate access and what right-to-try laws change?

Tap an answer to see the full explanation. Nothing is recorded or graded.